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Abstract
Most of the bone, cartilage, and connective tissue of the craniofacial region arise from cephalic neural crest cells. Presumably, patterning
differences in crest cells are a result of regional action of transcription factors within the developing pharyngeal arches. The basic
helix–loop–helix transcription factor dHAND/HAND2 is expressed throughout much of the neural crest-derived mesenchyme of the
pharyngeal arches, suggesting that it plays a crucial role in craniofacial development. However, targeted inactivation of the dHAND gene
results in embryonic lethality by E10.5 due to vascular defects, preventing further analysis of the role of dHAND in cephalic neural crest
cell development. In order to examine putative roles of dHAND during later stages of embryogenesis, we have used a transgenic lineage
marker approach, in which a portion of the dHAND upstream region containing an enhancer that directs dHAND expression to the
pharyngeal arches is used to drive Cre recombinase expression. By crossing these dHAND-Cre transgenic mice with R26R mice, we can
follow the fate of cells that expressed dHAND at any time during development by examining -galactosidase activity. We show that dHAND
is first expressed in postmigratory cephalic neural crest cells within the pharyngeal arches. In older embryos, -galactosidase-labeled cells
are observed in most of the neural crest-derived lower jaw skeleton and surrounding connective tissues. However, labeled cells only
contribute to substructures within the middle ear, indicating that our transgene is not globally expressed in cephalic neural crest cells within
the pharyngeal arches. Moreover, dHAND-Cre mice will provide a valuable tool for tissue-specific inactivation of gene expression in
multiple tissue types of neural crest origin.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Among events in skeletogenesis, craniofacial morpho-
genesis is perhaps the most intriguing, partially due to the
origin of the bone, cartilage, and connective tissue that
composes the face and neck. While bone and cartilage
throughout the body and skull vault are of mesodermal
origin (Noden, 1983; Jiang et al., 2002), those in the facial
region are derived from cephalic neural crest cells (Bronner-
Fraser, 1995; Le Douarin, 1982; Noden, 1988). These cells
arise along the lateral edge of the neural folds and begin a
ventral migration around the time of neural tube closure,
undergoing an epithelial-to-mesenchymal transformation
during the process (Le Douarin et al., 1993; Serbedzija et
al., 1992). They eventually come to reside in the pharyngeal
arches, transient structures on the ventral aspect of the
embryo, in which crest-derived ectomesenchymal cells con-
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tinue to proliferate and differentiate, eventually giving rise
to adult craniofacial structures.
Numerous signaling molecules direct the patterning and
development of cephalic neural crest cells and their deriv-
atives (Francis-West et al., 1998; Mina, 2001; Wilkie and
Morriss-Kay, 2001). These signals include Wnt1 and Wnt3a
[expansion of premigratory neural crest cells prior to mi-
gration (Ikeya et al., 1997)], AP-2 [migration of crest cells
to the arches (Schorle et al., 1996; Zhang et al., 1996)], and
members of the Distal-less gene family [postmigratory pat-
terning and differentiation (for reviews, see Kraus and
Lufkin, 1999; Merlo et al., 2000)]. It is during this last
postmigratory time period that soluble factors emanating
from the overlying epithelium trigger signaling cascades
within crest-derived ectomesenchymal cells that subse-
quently provide patterning and differentiation information
necessary for development of bone and cartilage structures
of the face and neck (Clouthier et al., 2000; Thomas and
Sharpe, 1998; Tucker et al., 1999). These epithelial expres-
sion domains appear to be tightly controlled, thus providing
much of the spatial specificity in transcription factor expres-
sion in the underlying mesenchyme. However, it is also
believed that crest cells of specific lineages may also be
programmed to express or respond to specific signals (Dor-
sky et al., 1998).
Two factors expressed in the pharyngeal mesenchyme
are the basic helix–loop–helix transcription factors
dHAND/HAND2 and eHAND/HAND1 (Cserjesi et al.,
1995; Hollenberg et al., 1995; Srivastava et al., 1995). The
genes encoding these factors are expressed in numerous
locations within the embryo, including postmigratory crest
cells in the arches. Their expression domains partially over-
lap, with dHAND expression observed throughout the mes-
enchyme of mandibular arch 1 and arches 2–6, whereas
eHAND expression is confined to the ventral one-third of
the mandibular arch one and arch two. While their expres-
sion patterns suggest that they might play crucial roles in
craniofacial morphogenesis, targeted inactivation of the
dHAND (Srivastava et al., 1997; Thomas et al., 1998) and
eHAND (Firulli et al., 1998; Riley et al., 1998) genes in
mice results in early embryonic lethality, thus preventing
further analysis of their roles in cephalic neural crest cell
development. However, some inferences on the role of
dHAND can be made from studies in endothelin-A (ETA)
receptor-deficient embryos, in which dHAND expression
within the arch mesenchyme is almost completely down-
regulated (Clouthier et al., 2000). ETA/ embryos are born
with severe craniofacial defects, including absence or mal-
formation of the mandible, Meckel’s cartilage, malleus,
incus, and tympanic ring (Clouthier et al., 1998). While
expression of at least five genes, including dHAND and
eHAND, is disrupted in the arch mesenchyme of ETA/
embryos (Clouthier et al., 2000; and D.E.C., unpublished
data), the dHAND expression domain encompasses most of
the expression domains of other affected genes, suggesting
that dHAND may play a dominant role in development of
craniofacial bones and cartilages.
Recently, we have shown using an 11-kb fragment of the
dHAND upstream region driving transgenic expression of
lacZ that dHAND expression is observed in facial bones and
cartilage until at least E16.75 (Charite´ et al., 2001). These
included portions of the mandible and Meckel’s cartilage, as
well as the tongue musculature and connective tissue of the
lower jaw. To further examine potential roles of dHAND
during craniofacial development, we have undertaken a
lineage analysis of cells that express dHAND at any time
during development. To accomplish this, we created trans-
genic mice in which a portion of the dHAND upstream
region containing elements necessary for expression in the
pharyngeal arch mesenchyme was used to drive Cre recom-
binase expression. By crossing dHAND-Cre transgenic
mice with mice from the Cre reporter line R26R (Soriano,
1999), we determined the fate of dHAND-lineage cells by
staining for -galactosidase activity and then compared the
staining with both staining in dHAND-lacZ transgenic em-
bryos and endogenous dHAND expression as judged by in
situ hybridization. We find that, during craniofacial mor-
phogenesis, Cre expression in dHAND-Cre;R26R embryos
is first detected in neural crest-derived pharyngeal arch
mesenchyme at E9.5, matching both the expression of the
dHAND-lacZ transgene and endogenous dHAND expres-
sion. In older dHAND-Cre;R26R embryos, labeled cells
become restricted to a limited number of neural crest-de-
rived structures, including Meckel’s cartilage, mandibular
bone, dental pulp of mandibular teeth, and the mesenchyme
surrounding the developing submandibular gland buds.
Most striking is the restriction of staining observed in the
middle ear ossicles, with only the manubrium of the malleus
containing labeled cells. No cells are observed in the body
of the malleus, incus, or stapes. In dHAND-lacZ embryos, a
similar distribution of labeled cells is observed in most
structures, though apparent differences in fated vs active
expression exist within craniofacial cartilages and mandib-
ular teeth. We observe very little endogenous dHAND ex-
pression in older embryos, with the primary exception being
around the mandibular incisors. Together, our findings il-




The plasmid pOG231 contains a CMV promoter, a syn-
thetic intron, the Cre cDNA, a nuclear localization signal
(NLS), and a SV40 polyadenylation signal (O’Gorman et
al., 1997). To create the dHAND-Cre transgene, pOG231
was digested with XhoI, treated with Klenow enzyme to
produce blunt ends, and then digested with EcoRI. This
scheme liberated a 1.8-kb fragment containing the synthetic
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intron, Cre-NLS, and polyadenylation sequences. This frag-
ment was then subcloned into pSP73 (Promega) cut with
EcoRI and EcoRV, resulting in the plasmid pSP73-Cre-
NLS. This plasmid was then digested with KpnI, treated
with T4 DNA polymerase to produce blunt ends, followed
by digestion with XhoI and gel purification. To prepare the
promoter insert, pBSdHAND-lacZ (Charite´ et al., 2001),
containing 11 kb of the dHAND upstream region, was cut
with SfiI (3 to the dHAND transcription initiation site),
treated with T4 DNA polymerase to produce blunt ends,
followed by restriction with XhoI (7.4 kb upstream of the
SfiI site). The isolated 7.4-kb SfiI (b)–XhoI fragment was
then subcloned into pSP73-Cre-NLS [KpnI (b)–XhoI]. The
resulting plasmid, pdHAND-Cre, was verified by restriction
digest and partial sequencing. The final 9.2-kb construct
was isolated by restriction enzyme digest with SalI. The
fragment was isolated on a 0.8% ultra-pure agarose gel
(FMC), purified by perchlorate elution, and quantified
(Comerford et al., 1995).
Production of transgenic mice
Construction and characterization of the 11-kb
dHAND-lacZ transgenic mice has previously been described
(Charite´ et al., 2001; McFadden et al., 2000). To construct
dHAND-Cre transgenic mice, the purified dHAND-Cre con-
struct was injected at 3 ng/l into C57BL6/J  SJL F2
fertilized one-cell eggs, and two-cell embryos were trans-
ferred to pseudopregnant females as previously described
(Clouthier et al., 1997). Initial genotyping of putative
founders was performed by dot blot hybridization. Five
founder mice were identified, with transgene copy number
ranging from 1 to 10 copies per cell. Founder mice were
bred to mice from the Cre reporter mouse strain R26R
(strain 129/Sv-Gtrosa26tm/Sor; The Jackson Laboratory, Bar
Harbor, ME) (Soriano, 1999). Embryos were collected at
E10.5 and analyzed for -galactosidase (-gal) staining to
evaluate the fidelity and robustness of Cre expression. Three
lines were established that produced compound hemizygous
pups with -gal activity. While all three lines showed sim-
ilar expression patterns, embryos from lines 7-1 and 7-2 had
the most robust staining. Therefore, these lines were used
for the current study.
Genotyping of dHAND-Cre transgenic mice and embryos
Genotyping was performed by PCR using genomic DNA
isolated from a small tail biopsy or embryonic yolk sac. The
presence of the dHAND-Cre transgene was determined by
using the Cre primers 5-GGACATGTTCAGGGATCGC-
CAGGCG-3 and 5-GCATAACCAGTGAAACAGCATT-
GCTG-3 as previously described (Kisanuki et al., 2001).
The presence of the R26R allele was determined by using
primers 5-GCGAAGAGTTTGTCCTCAACC-3 (R1295)
and 5-AAAGTCGCTCTGAGTTGTTAT-3 (R26RF) as
previously described (Soriano, 1999). The presence of the
dHAND-lacZ transgene was determined by using the lacZ
primers 5-GACACCAGACCAACTGGTAATGG-3 and
5-GCATCGAGCTGGGTAATAAGCG-3. Bands were
visualized on 1% agarose gels.
-Galactosidase staining
For whole-mount staining [embryonic day (E) 8.5 to
E11.5], embryos were collected and fixed for 1 h in 4%
paraformaldehyde on ice. Embryos were then rinsed in lacZ
rinse buffer (0.2 M sodium phosphate, pH 7.3, 2 mM mag-
nesium chloride, 0.02% NP-40, 0.01% sodium deoxy-
cholate) twice for 10 min and then placed in lacZ staining
buffer (lacZ rinse buffer plus 5 mM potassium ferricyanide,
5 mM potassium ferrocyanide, and 1 mg/ml X-gal) and
incubated overnight in the dark at room temperature. Em-
bryos were rinsed in PBS, postfixed in 10% neutral-buffered
formalin for 4 h, rinsed in PBS, and stored in 70% ethanol.
Embryos were analyzed and photographed on an Olympus
SZX12 stereomicroscope fitted with a DP11 digital camera.
To observe -gal staining at the cellular level, some of these
stained embryos were dehydrated through graded ethanols
and Cedarwood oil (Polysciences) and then embedded in
paraffin and sectioned at 12 microns on a Lecia RM2135
microtome. Sections were collected on positively charged
Superfrost Plus microscope slides (Fisher Scientific), par-
tially rehydrated, counterstained with nuclear fast red, de-
hydrated, and coverslipped with DPX mounting media
(BDH). Analysis of sections was performed by using a
Nikon E600 microscope with an attached SPOT RT digital
camera.
For staining of older embryos (E13.5–E18.5), embryos
were isolated into PBS and immediately snap frozen in OCT
on a dry ice/95% ethanol bath. Embryos were sectioned at
14–18 microns on a CM1900 cryostat (Leica). Sections
were collected on Superfrost Plus slides, air dried for 2 h,
fixed in 0.5% gluteraldehyde at room temperature for 30
min, washed three times for 20 min each in lacZ rinse
buffer, and incubated overnight in lacZ staining solution at
37°C. After rinsing in PBS, slides were counterstained in
nuclear fast red (E8.5–E15.5) or eosin (E18.5) and cover-
slipped with PBX mounting media. Analysis and photogra-
phy was performed as described above.
In situ hybridization analysis
Sectional in situ hybridization analysis was performed as
previously described (Shelton et al., 2000) by using a 35S-
UTP-labeled riboprobe against dHAND (Srivastava et al.,
1997), with the hybridization carried out at 70°C in hybrid-
ization buffer containing 0.75 M NaCl. Sections were ex-
posed for 2–3 weeks before developing, fixing, and coun-
terstaining with Richard Allen hematoxylin 2 (VWR).
Whole-mount in situ hybridization analysis was performed
as previously described by using a digoxigenin-labeled ri-
boprobe against dHAND (Clouthier et al., 2000). Following
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staining for alkaline phosphatase activity, embryos were
photographed, embedded in paraffin, and sectioned at 16
microns. Sections were not counterstained. Photography
was performed by using Nomarski DIC optics.
Results
Creation of dHAND-Cre transgenic mice
We initially set out to create a mouse strain in which we
could follow the fate of dHAND-expressing cells throughout
embryonic development. To accomplish this, we con-
structed a transgene in which a 7.4-kb fragment of the
dHAND upstream region, which contains enhancer elements
necessary for both cardiac and pharyngeal arch expression
of dHAND (Charite´ et al., 2001; McFadden et al., 2000),
was used to drive expression of Cre recombinase (Fig. 1).
Microinjection of this construct resulted in five transgenic
founder mice. To assess expression of the transgene,
founder animals were bred with mice from the R26R Cre
reporter line (Soriano, 1999). Expression of Cre in R26R
mice results in activation of a lacZ gene and thus robust
-galactosidase (-gal) staining, providing an indelible
marker of cells that have expressed dHAND at any time
during development. E10.5 dHAND-Cre;R26R embryos
were collected from each line and assayed by -gal staining.
Three lines showed staining in the heart and pharyngeal
arches in a dHAND-specific manner (data not shown); two
of these (7-1 and 7-2) were subsequently used in the anal-
yses described below. Findings were identical in both lines,
though overall intensity of expression was less in the 7-2
line.
dHAND-Cre expression during early embryogenesis
We initially examined -gal staining in early dHAND-
Cre;R26R embryos. Since -gal staining could represent
either active or past dHAND enhancer activity, we also
examined -gal staining in 11.0-kb dHAND-lacZ trans-
genic mouse embryos and compared that with the endoge-
nous dHAND expression pattern. Though our dHAND-lacZ
transgenic mouse line contained an additional 3.6 kb of
upstream promoter region, both dHAND-lacZ and dHAND-
Cre transgenic strains contained the same pharyngeal arch
enhancer. Further, in our previous studies, 11.0 kb
dHAND-lacZ and 7.4 kb dHAND-lacZ embryos had iden-
tical -gal staining patterns in the developing pharyngeal
arches (Charite´ et al., 2001).
Staining was first observed in dHAND-Cre;R26R em-
bryos at E7.75 in the cardiac crescent (data not shown),
matching the endogenous dHAND expression pattern (Sriv-
astava et al., 1997). By E8.5, expression was observed in the
lateral plate mesoderm and common ventricle of the heart
but not in the pharyngeal arches, a finding recapitulated in
dHAND-lacZ embryos (data not shown) and matching the
endogenous dHAND expression pattern (Charite´ et al.,
2000; Srivastava et al., 1997). However, the staining in the
lateral plate mesoderm of dHAND-Cre;R26R was more re-
stricted than the endogenous dHAND expression pattern. By
E9.5, labeled cells in dHAND-Cre;R26R embryos were ob-
served within much of the neural crest-derived mesenchyme
of mandibular arch 1, with scattered cells also observed in
the medial mesenchyme of arch 2 (Fig. 2A). Labeled cells
were not observed in the overlying arch epithelium (Fig.
2A). This staining pattern was identical to that observed in
dHAND-lacZ embryos, though labeled cells were primarily
confined to arch one (Fig. 2B and B). -gal staining in both
of these transgene lines closely matched the endogenous
dHAND expression pattern (Fig. 2C and C), suggesting that
the arch staining in dHAND-Cre;R26R embryos represented
active dHAND expression.
-gal staining in E9.5 dHAND-Cre;R26R embryos was
also observed in the neural crest-derived cervical dorsal root
ganglia (DRG) (black arrow in Fig. 2A), a site that is not
stained in dHAND-lacZ embryos (Fig. 2B) and that does not
show any endogenous expression (Fig. 2C). These findings,
along with the fact that the degree of labeling in the DRGs
differed in different dHAND-Cre;R26R lines examined,
suggest that the DRG staining is artifactual. Labeled cells in
dHAND-Cre;R26R embryos were also present in the foregut
and forelimb buds. Expression in the forelimb bud was
unusually strong for the embryonic age of the embryo in
comparison with the endogenous limb expression pattern of
Fig. 1. Diagram of the dHAND-Cre transgene. A 7.4-kb fragment of the dHAND upstream region, containing enhancers required for pharyngeal arch and
cardiac expression, was fused to a Cre cDNA containing nuclear localization and SV40 polyadenylation sequences. A synthetic intron resides in the 5 end
of the Cre cDNA to aid transgene expression. Bg, BglII; Kp, KpnI; Sf, SfiI; Xh, XhoI.
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Fig. 2. Early dHAND expression domains in dHAND-Cre; R26R embryos. (A–F) Lateral (A–F) and transverse (A–F) views of dHAND-Cre;R26R (A, A;
D, D) and dHAND-lacZ (B, B; E, E) embryos stained in whole mount for -gal activity and wild type embryos (C, C; F, F) after whole-mount in situ
hybridization analysis of dHAND expression. Transverse sections of -gal-stained embryos were counterstained with nuclear fast red and photographed by
using brightfield optics. Transverse sections of whole-mount in situ embryos were photographed by using Nomarski DIC optics. (A) In E9.5 dHAND-Cre;
R26R embryos, labeled cells are observed in the first mandibular (1) and second (2) arches, common heart ventricle (h), and forelimb bud (lb). Few scattered
cells are observed in the early dorsal root ganglion (black arrow). (A) A transverse section through the first arch of the embryo shown in (A) illustrates that
stained cells are confined to the arch mesenchyme in a dHAND-specific pattern. (B) In E9.5 dHAND-lacZ embryos, staining is observed in the mandibular
arch and common heart ventricle. (B) A transverse section through the first arch of the embryo shown in (B) shows that labeled cells are confined to the
arch mesenchyme. (C) In E9.5 wild type embryos, dHAND expression is observed in the first mandibular and second arches and in the future right ventricle
of the heart (obscured by the left ventricle). (C) As observed in (A) and (B), dHAND expression is confined to the arch mesenchyme. (D) By E10.5, labeled
267L.-B. Ruest et al. / Developmental Biology 257 (2003) 263–277
dHAND (Fig. 2C; and Charite´ et al., 2000; Fernandez-Teran
et al., 2000; Srivastava et al., 1995). Further, while the
endogenous dHAND gene is expressed in the posterior limb
bud, labeled cells in E9.5 dHAND-Cre;R26R embryos were
observed in the anterior portion of the forelimb. There was
no apparent labeling of limb bud mesenchyme in dHAND-
lacZ embryos (Fig. 2B).
By E10.5, the more caudal arches in dHAND-Cre;R26R
embryos also contained labeled cells; other sites of expres-
sion remained unchanged (Fig. 2D). Within the arches,
labeled cells appeared denser around the arch periphery
(Fig. 2D), resembling the pattern previously observed for
neural crest cells (Chai et al, 2000). With the exceptions
noted at E9.5, the overall expression pattern still resembled
-gal staining in dHAND-lacZ embryos (Fig. 2E and E)
and endogenous dHAND expression (Fig. 2F and F),
though very few labeled cells were observed in arches 3–6
of dHAND-lacZ embryos. These findings suggest that the
arch staining in dHAND-Cre;R26R embryos was still a
result of active dHAND expression. While staining in loca-
tions other than the arches or derivatives continued through-
out development in dHAND-Cre;R26R embryos, the major-
ity of the present study focuses on findings during
craniofacial development.
Fate of cells from a dHAND lineage during orofacial
development
Using dHAND-lacZ transgenic mice, we have previously
shown that dHAND is expressed in subsets of cells during
orofacial development (Charite´ et al., 2001). To more di-
rectly determine the participation of dHAND lineage cells
in this process, we examined -gal staining in E13.5 and
E18.5 dHAND-Cre;R26R embryos and compared that to
both -gal staining in dHAND-lacZ embryos and endoge-
nous dHAND expression in wild type embryos. In E13.5
dHAND-Cre;R26R and dHAND-lacZ embryos, Meckel’s
cartilage and surrounding perichondrium, as well as man-
dibular bone and surrounding connective tissue, all neural
crest derivatives, were composed of labeled cells (Fig. 3A
and B). The mesenchyme surrounding the buds and ducts of
the developing submandibular gland (pseudoglandular
stage), a neural crest derivative (Jaskoll et al., 2002), was
also composed of -gal-stained cells (see insets, Fig. 3A
and B). The ductal epithelium did not contain labeled cells.
Mesodermal derivatives also contained labeled cells, in-
cluding the lamina propria of the tongue. One notable dif-
ference was that Meckel’s cartilage in dHAND-lacZ em-
bryos was composed of both labeled and unlabeled cells,
compared with almost complete contribution of labeled
cells in dHAND-Cre;R26R embryos. Endogenous dHAND
gene expression was observed in the lamina propria of the
tongue and in the submandibular gland mesenchyme,
though the latter appeared to be more restricted than ob-
served in dHAND-lacZ embryos (Fig. 3C). Expression in
the early mandibular bone and Meckel’s cartilage was vir-
tually undetectable. The other major site of labeled cells in
E13.5 dHAND-Cre;R26R embryos was in the developing
scapula, in which labeled cells composed the entire coracoid
process and acromion of the scapula, but were mixed with
unlabeled cells in the scapula blade (data not shown). The
significance of this scapular staining is unclear, as endoge-
nous dHAND expression was not observed in these struc-
tures at E13.5 (data not shown).
By E18.5, the mandibular bone and surrounding lamina
propria of dHAND-Cre;R26R embryos was composed of
labeled cells along its entire proximodistal axis (Fig. 3D and
G; and data not shown). Likewise, Meckel’s cartilage was
also stained along its entire axis (Fig. 3D and G; and data
not shown), as were the chondrocytes and surrounding peri-
chondrium composing the anterior and lateral processes of
the proximal mandible (Fig. 3G). The extent of cell labeling
decreased near the junction of the processes with the man-
dibular bone, a zone composed of hypertrophic and presum-
ably ossified chondrocytes (see inset, Fig. 3G). Labeled
cells were also observed throughout the tongue, with stron-
gest staining again in the lamina propria (Fig. 3D), though
the relative number of labeled cells appeared greater in the
oral portion (distal two-thirds) than in the pharyngeal por-
tion (proximal one-third) of the tongue (data not shown).
In dHAND-lacZ embryos, labeled cells were also ob-
served throughout the proximodistal axis, though the rela-
tive presence of cells was higher in the caudal portion of the
mandible along this axis (Fig. 3E). Labeled cells were also
present in Meckel’s cartilage, though they again were mixed
with unlabeled cells (Fig. 3E and H). Very few labeled cells
were observed in the mandibular processes, though strong
staining was observed in the perichondrium around both
these processes and Meckel’s cartilage (Fig. 3E and H).
Endogenous dHAND expression was only observed in scat-
tered cells within the mandible (Fig. 3F and I). Expression
cells in dHAND-Cre;R26R embryos are observed in arches 1–3, the ventricle, and the limb bud. Scattered cells are also observed in the atrium. While not
visible in this view, stained cells are also observed in arch 4. Labeled cells are also observed in the cervical dorsal root ganglion (black arrows). (D) In a
transverse section through the first and second arches, staining is observed in the arch mesenchyme, with the intensity of staining highest in the periphery
of the arch. (E) In E10.5 dHAND-lacZ embryos, labeled cells are observed in arches one and two and in the ventricles of the heart. Scattered cells are also
present in the atria. (E) As observed in dHAND-Cre;R26R embryos, staining within the mesenchyme of the first arch is strongest at the periphery. While
not shown due to a slight difference in the angle of section, the second arch staining in dHAND-lacZ embryos is comparable with that of dHAND-Cre;R26R
embryos. (F) dHAND expression in E10.5 wild type embryos is observed in arches 1–4, distal limb buds, and right ventricle of the heart. (F) A section
through the first and second arch again illustrates staining throughout the medial half of the arch mesenchyme, with the strongest staining observed along
the periphery of the arch.
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was not observed in the perichondrium of the mandibular
processes.
Contribution of dHAND lineage cells in middle ear and
throat structures
Much of the external and middle ear is composed of
ectomesenchymal cells derived from the first and second
arches (Fekete, 1999; Kontges and Lumsden, 1996; Mallo,
2001; Noden, 1988). In E13.5 dHAND-Cre;R26R embryos,
most of the mesenchyme composing the connective tissue in
the external region was composed of -gal-positive cells
(Fig. 4A), though the epithelium of the future external
auditory meatus (derived from the first pharyngeal cleft)
was unstained (arrow). In the middle ear, labeled cells were
observed in Meckel’s cartilage as described above, though a
strict delineation of labeled and unlabeled cells occurred at
the junction with the cartilaginous precursor of the malleus,
which was unlabeled (data not shown). However, labeled
cells were observed in the distal malleus (Fig. 4A). Further,
while most of the stapes was composed of unlabeled cells,
the caudal stapes and surrounding perichondrium did con-
tain a mixture of labeled and unlabeled cells (data not
shown). We also observed labeled cells in the sympathetic
ganglion, though there was extensive mixing with unlabeled
cells (see inset, Fig. 4A). Other sites of expression included
the cervical dorsal root ganglia, superior cervical sympa-
thetic trunk, and ventral primary ramus of the cervical nerve
(data not shown). As observed for the sympathetic ganglion,
contribution of labeled cells within these structures was
scattered.
A similar pattern of -gal staining was observed in
dHAND-lacZ embryos, though labeled cells in Meckel’s
cartilage were mixed with unlabeled cells (Fig. 4B), while
the sympathetic ganglion was composed solely of unlabeled
cells (see inset, Fig. 4B). This pattern of labeled cells was
not necessarily reflected in the endogenous expression of
dHAND, as very little expression was observed in the ex-
ternal or middle ear, though intense signal was present in the
sympathetic ganglion and the mandibular branch of the
trigeminal nerve (*) (Fig. 4C).
At E18.5, the tympanic ring and gonial bones, neural
crest-derived structures formed by intramembranous ossifi-
cation, were composed of labeled cells in dHAND-Cre;
R26R embryos, as was the surrounding connective tissue
and Meckel’s cartilage (Fig. 4D). Of the middle ear ossicles,
only the manubrium of the malleus contained labeled cells;
the cartilaginous precursors of the incus or stapes were
unlabeled (Fig. 4G and J). Other elements composed of
labeled cells included the distal portion of the styloid car-
tilage and cartilage associated with the pinna, with scattered
cells also present in the sympathetic ganglion (Fig. 4M and
4M). Labeled cells in E18.5 dHAND-lacZ embryos were
observed in a similar pattern, with staining observed in the
tympanic and gonial bones (Fig. 4E), Meckel’s cartilage
(Fig. 4E), the manubrium of the malleus (Fig. 4H), and the
styloid cartilage (Fig. 4N). However, as observed at E13.5,
labeled cells in cartilage structures, while composing most
of the perichondrium around the structures, were exten-
sively mixed with unlabeled cells within the cartilage. This
was most prominent in the styloid cartilage (Fig. 4N). La-
beled cells were not present in the sympathetic ganglion
(Fig. 4N). Endogenous dHAND expression was not widely
observed, with virtually no expression observed in any of
the middle ear structures examined (Fig. 4F, I, and L).
However, as observed at E13.5, expression was observed in
the sympathetic ganglion (Fig. 4O).
Labeled cells were also observed in the second and third
arch derivatives of dHAND-Cre;R26R embryos. The hyoid
bone of the throat is actually derived from three cartilagi-
nous precursors derived from both arches. The lesser horns,
a second arch derivative, were composed exclusively of
labeled cells (Fig. 4P). However, the greater horns, a third
arch derivative, were composed of both labeled and unla-
beled cells (data not shown). The body of the hyoid, derived
from both arches (Kontges and Lumsden, 1996), was also
composed of a mixture of labeled and unlabeled cells in the
cartilaginous portions (endochondral ossification begins in
the middle of the body and spreads bilaterally). However,
fewer hypertrophic chondrocytes and presumably ossified
chondrocytes were labeled, similar to our observations in
the mandibular processes. Scattered labeled cells were ob-
served in the fourth arch-derived thyroid cartilage (data not
shown). Labeled cells were also present in the mesenchyme
composing the submandibular and sublingual glands (ar-
rows in Fig. 4P) and in adipose tissue of the neck (see inset,
Fig. 4P).
In E18.5 dHAND-lacZ embryos, -gal cells were ob-
served in the perichondrium surrounding the lesser horns of
the hyoid, with few labeled cells actually composing the
lesser horns or hyoid body (Fig. 4Q). Labeled cells were
also present in the submandibular and sublingual gland
mesenchyme (arrow in Fig. 4Q), but were absent in adipose
tissue (see inset, Fig. 4Q). In contrast to this staining
pattern, very little dHAND expression was detected by in
situ hybridization in any hyoid structures (Fig. 4R), in stark
contrast to the strong signal detected in adipose tissue.
Expression was also detected in the submandibular and
sublingual glands (see inset, Fig. 4R).
Expression of dHAND during odontogenesis
During odontogenesis, cephalic neural crest cell-derived
ectomesenchyme contributes to the formation of odonto-
blasts (and consequently dentin matrix), dental pulp, cemen-
tum, and the periodontal ligaments of the incisors and mo-
lars (Chai et al., 2000). To examine potential roles of
dHAND signaling in this process, we examined the extent
of -gal-stained cells at different stages of tooth develop-
ment in dHAND-Cre;R26R embryos. As with our other
analyses, we compared this staining with that observed in
age-matched dHAND-lacZ embryos and with endogenous
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dHAND expression. At E13.5, tooth development is at the
bud stage, which is characterized by proliferative areas
(composed of neural crest-derived mesenchyme) surround-
ing the dental bud that ultimately forms the enamel organ.
As shown in Fig. 5, these proliferative areas were composed
solely of labeled cells around both mandibular incisor (Fig.
Fig. 3. Contribution of dHAND lineage cells to arch-derived structures of the jaw of dHAND-Cre;R26R embryos. Transverse (A–C) and frontal (D–I) sections
through the heads of dHAND-Cre;R26R (A, D, G), dHAND-lacZ (B, E, H), and wild type (C, F, I) embryos. Frozen sections from dHAND-Cre;R26R and
dHAND-lacZ embryos were stained for -gal activity and counterstained with nuclear fast red (E13.5) or eosin (E18.5). Paraffin sections from wild type
embryos were probed with a 35S-labeled riboprobe against dHAND. After developing, sections were counterstained with Harris hematoxylin and
photographed under darkfield conditions. To aid in the visualization of specific structures, yellow lines have been added to some of the darkfield panels. (A–C)
Transverse sections through the lower jaw of E13.5 embryos. (A) Labeled cells in dHAND-Cre;R26R embryos are observed in structures derived from the
first pharyngeal arch, including mandibular bone (md), Meckel’s cartilage (mc), tongue (t), and surrounding mesenchyme/connective tissue. Abundant labeled
cells are also observed in the mesenchyme of the developing submandibular glands (smg), but not in the glandular epithelium (see inset, A). The mesenchyme
of the upper jaw (future maxilla; *) and oral cavity epithelium do not contain labeled cells. (B) Labeled cells in dHAND-lacZ transgenic embryos are observed
in a similar pattern to those in dHAND-Cre;R26R embryos, though labeled cells in Meckel’s cartilage are mixed with unlabeled cells. (C) Endogenous dHAND
expression is observed in the lamina propria of the tongue and in the mesenchyme surrounding the proximal ducts of the submandibular gland. Very little
expression is observed in the mandible or Meckel’s cartilage. (D–I) Frontal sections through the mandible of E18.5 embryos. (D) -gal-stained cells in
dHAND-Cre;R26R embryos are present in the connective tissue of the tongue (t), with highest staining in the lamina propria (black arrow). Almost all cells
in the mandible, Meckel’s cartilage (yellow arrow), and surrounding mesenchyme are also labeled. (E) Labeled cells in dHAND-lacZ embryos are again
observed in a similar pattern to those in dHAND-Cre;R26R embryos. However, a mixture of labeled and unlabeled cells composes the mandibular bone and
Meckel’s cartilage. (F) Faint dHAND expression is observed in the mandibular bone. Very little expression is observed in Meckel’s cartilage. The asterisks
in (D–F) mark the enamel organ of the left incisor. (G) In a more proximal section to that shown in (D–F), labeled cells in dHAND-Cre;R26R embryos are
observed in Meckel’s cartilage and in the articular (ap) and coronoid (cp) processes of the mandible and surrounding perichondrium. However, fewer labeled
cells are observed near the junction with the ossified mandible, an area undergoing endochondral ossification and composed of hypertrophic chondrocytes
(see inset, G). (H) Labeled cells are mixed with unlabeled cells in Meckel’s cartilage, but are not observed in the anterior and coronoid processes of the
mandible. The perichondrium surrounding the process is composed almost solely of labeled cells. (I) Endogenous dHAND expression is not observed in the
mandibular processes or in Meckel’s cartilage, though expression is observed in the sympathetic ganglion (yellow arrow). Due to the angle of section, this
structure is not observed in the dHAND-Cre-R26R or dHAND-lacZ embryo sections, though scattered labeled cells are present in the sympathetic ganglion
of dHAND-Cre-R26R embryos (see Fig. 4). mo, molar.
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5A) and molar (Fig. 5D) buds of dHAND-Cre;R26R em-
bryos. Labeled cells were not observed around the maxillary
incisor and molar buds (Fig. 5D and data not shown).
-gal-positive cells in E13.5 dHAND-lacZ embryos were
also observed in the neural crest-derived mesenchyme sur-
rounding the enamel organs of mandibular incisors (Fig.
5B), but were absent around the mandibular molars (Fig.
5E). Likewise, endogenous dHAND expression was only
observed in the mandibular incisor mesenchyme surround-
ing the enamel organs (Fig. 5C). Expression was not ob-
served in Meckel’s cartilage (Fig. 5C) or around the man-
dibular molars (Fig. 5F). These findings thus indicate that
the staining in the incisors of E13.5 dHAND-Cre;R26R
embryos represents actual expression, while the staining
around the molar buds represents fated expression.
By E15.5, odontogenesis has reached the cap stage, at
which time the nonlabeled epithelial component of the de-
veloping tooth has begun to take the shape of the future
tooth. Labeled cells comprising the dental papilla of both
the mandibular molars and incisors were observed beneath
the unlabeled epithelial cap in dHAND-Cre;R26R embryos
(Fig. 5G and J). The relative number of unlabeled cells
seemed to be higher in the molar papilla (arrow in Fig. 5G)
than in the incisor papilla. The surrounding mandibular
bone, symphysis of Meckel’s cartilage, and mesenchyme
were also labeled. -gal-positive cells were also observed in
the dental papilla of the incisors of dHAND-lacZ embryos,
though were mixed with unlabeled cells in the symphysis of
Meckel’s cartilage (Fig. 5H). Labeled cells were again ab-
sent in the molar papilla (arrow in Fig. 5K). Endogenous
dHAND expression was only observed in the incisor dental
papilla and surrounding mesenchyme (Fig. 5I). As observed
at E13.5, expression was absent in the dental papilla of
lower molars (Fig. 5L) and Meckel’s cartilage (Fig. 5I),
again suggesting differences in actual vs fated expression in
the incisors and molars of dHAND-Cre;R26R embryos.
At E18.5, the distribution of dHAND progeny cells in the
teeth of dHAND-Cre;R26R embryos was essentially un-
changed. Dentin matrix, encompassing odontoblastic pro-
cesses within dentinal tubules, showed strong staining in
both developing mandibular incisors (Fig. 5M) and molars
(Fig. 5P). Unlabeled cells were obvious in the dental papilla,
likely reflecting the observed neural crest and nonneural
crest contribution to the dental pulp (Chai et al., 2000).
However, this mixing was once again more prominent in the
molar pulp. The mandibular bone and surrounding mesen-
chyme were also composed of labeled cells. The entire
enamel organ, including inner and outer enamel epithelial
cells and the residual dental lamina, was unlabeled. Labeled
cells were not observed in any part of the developing max-
illary incisors (data not shown), though a few scattered cells
were observed in the maxilla (data not shown).
In E18.5 dHAND-lacZ embryos, labeled cells were ob-
served in the bone and mesenchyme surrounding the man-
dibular incisor dental papilla, with labeled cells in the sym-
physis of Meckel’s cartilage mixed with unlabeled cells
(Fig. 5N). While -gal-positive cells were present in the
mandibular bone surrounding the lower molars, labeled
cells were not present in the molar dental papilla (Fig. 5Q).
This pattern closely reflected the endogenous dHAND ex-
Fig. 4. Distribution of dHAND progeny cells in the middle ear and throat during development of dHAND-Cre; R26R embryos. Transverse (A–C; E13.5) and
frontal (D–R; E18.5) sections through the middle ear and throat of dHAND-Cre;R26R (A, D, G, J, M, P), dHAND-lacZ (B, E, H, K, N, Q), and wild type
(C, F, I, L, O, R) embryos. Treatment of sections was performed as described in Fig. 3. (A–C) Sections through the middle ear of E13.5 embryos. (A) In
dHAND-Cre;R26R embryos, stained cells are observed in the mesenchyme surrounding the epithelium of the external auditory meatus (black arrow), in
Meckel’s cartilage (mc), and in the future manubrium of the malleus (m). Scattered labeled cells are also observed in the sympathetic ganglion (sg; see inset,
A). Labeled cells are not observed in the stapes (s), though are present in more proximal sections (see text). (B) Labeled cells in dHAND-lacZ embryos are
also observed in the mesenchyme of the middle ear region, the manubrium of the malleus, and Meckel’s cartilage, though they are mixed with unlabeled cells
in Meckel’s cartilage. No staining is observed in the stapes or sympathetic ganglion (see inset, B). (C) Very little endogenous dHAND expression is observed
in the middle ear. The exceptions are the sympathetic ganglion and the mandibular branch of the trigeminal ganglion (*). (D–R) Frontal sections through the
heads of E18.5 embryos. (D) The tympanic (ty) and gonial (g) bones and Meckel’s cartilage are composed almost solely of labeled cells in dHAND-Cre;R26R
embryos. The surrounding mesenchyme in this region of the head is also composed of labeled cells. (E) Labeled cells in dHAND-lacZ embryos are observed
in the tympanic ring and gonial bone, though a small portion of unlabeled cells are also present. More significant mixing of labeled and unlabeled cells is
observed in Meckel’s cartilage. (F) Little endogenous expression is observed in the tympanic and gonial bones and Meckel’s cartilage, though faint expression
is found along some of the head vasculature (arrow). (G, H) In sections through the malleus, labeled cells in dHAND-Cre;R26R and dHAND-lacZ embryos
are confined to the manubrium (mb) of the malleus and surrounding mesenchyme. (I) dHAND expression is not observed in any part of the malleus or incus
(i) in wild type embryos. (J, K) -gal-stained cells in dHAND-Cre;R26R and dHAND-lacZ embryos are not present in the incus or stapes (s). Labeled cells
in the manubrium of dHAND-lacZ embryos are mixed with unstained cells. (L) dHAND expression is not observed in the incus, stapes, or manubrium of the
malleus. (M) In sections through the distal portion of the styloid cartilage (st), labeled cells in dHAND-Cre;R26R embryos compose most of the styloid and
are scattered in the sympathetic ganglion (see inset, M). (N) In dHAND-lacZ embryos, labeled cells are present in the perichondrium of the styloid cartilage,
but are mixed in the cartilage itself and are absent in the sympathetic ganglion (see inset, N). (O) dHAND expression is observed in the sympathetic ganglion
in the incus/stapes region, with weaker expression in the glossopharyngeal ganglion. (P) In the throat, -gal-stained cells in dHAND-Cre;R26R embryos are
observed in the lesser horn (lh) and body (h) of the hyoid. However, labeled cells are mixed with unlabeled cells in the body, possibly reflecting changes
in staining in cartilage undergoing endochondral ossification, as few hypertrophic chondrocytes are stained. Labeled cells are also observed in the
mesenchyme of the submandibular and sublingual glands (black arrows). Out of the photographic frame, adipose tissue also contains scattered labeled cells
(inset, P). (Q) As with other cartilages, labeled cells in dHAND-lacZ embryos compose the perichondrium of the lessor horns of hyoid but are mixed with
a majority of unlabeled cells in the cartilage itself. Very few labeled cells are observed in the body of the hyoid. Labeled cells are observed in the mesenchyme
of the submandibular and sublingual glands (arrows), but are absent in adipose tissue observed out of the photographic frame (inset, Q). (R) dHAND
expression is not observed in or around the hyoid cartilages or bones; however, adipose tissue at the base of the neck shows strong dHAND expression. Out
of the plane of section, expression is also observed in the submandibular gland (inset, R). oc, otic capsule.
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pression pattern, with weak dHAND signal observed in the
mandibular incisor dental papilla, distal mandibular bone,
and surrounding mesenchyme (Fig. 5O). No signal was
detected in the mandibular molar or surrounding mesen-
chyme (Fig. 5R) or in Meckel’s cartilage (Fig. 5O).
Discussion
Craniofacial development is regulated by multiple hier-
archical signaling cascades that provide patterning and dif-
ferentiation information to cephalic neural crest cells and
their derivatives (Wilkie and Morriss-Kay, 2001). The tran-
scription factor dHAND is likely involved in one or more of
these cascades, based on previous studies of endogenous
and transgenic expression patterns. We have shown here
using fate analysis of dHAND progeny cells that dHAND
likely plays crucial roles in development of neural crest-
derived structures of the face, though based on our fate
analysis and comparison with dHAND-lacZ expression and
endogenous dHAND expression, the regulation of its ex-
pression is quite complex.
dHAND-Cre expression as a marker of current and past
dHAND expression
One advantage of using Cre expression to examine gene
expression patterns is the indelible nature of the staining,
allowing observation of cell fate (Chai et al., 2000). These
experiments also require cautious interpretation of resulting
expression patterns, as transgenic expression constructs can
lack elements necessary for complete gene expression or
silencing. Indeed, analysis of the Mrf4/Myf5 locus reveals
pharyngeal arch enhancer elements 88 kb upstream from the
transcription start site (Carvajal et al., 2001). In this study,
we have shown that labeled cells in dHAND-Cre;R26R
embryos are observed in almost all cranial structures in
which endogenous dHAND expression is observed (this
study and Howard et al., 2000; Srivastava et al., 1995, 1997;
Thomas et al., 1998). This includes the sympathetic gan-
glion, where dHAND-lacZ expression was not detected (this
study, and Charite´ et al., 2001). While expression of the
dHAND-lacZ transgene in the 11.0-kb line could be af-
fected by transgene insertion effects, it is more likely that
detection of dHAND-Cre expression is aided by the relative
strength of the ROSA26 promoter. The ROSA26 gene is
highly expressed in almost all embryonic and adult tissues
(Soriano, 1997, 1999) and may therefore compensate for
weak or partial enhancers, thus allowing weak Cre expres-
sion to be detected. This may be particularly true of the
sympathetic ganglion expression, considering the scattered
nature of staining in dHAND-Cre;R26R embryos vs the
robust endogenous expression at E13.5. Using dHAND-lacZ
deletion constructs, McFadden et al. (2000) demonstrated
that, while the entire cardiac enhancer for dHAND was not
required for expression of lacZ in the heart, partial enhanc-
ers resulted in an overall attenuation of cardiac expression.
Labeled cells in dHAND-Cre;R26R embryos are ob-
served in several locations that likely reflect ectopic expres-
sion or activation of enhancers within the dHAND upstream
region, including the DRG and limb bud. Aberrant induc-
tion of transgene expression by local enhancers surrounding
the integration site is well documented. In our previous
dHAND promoter study, limb bud expression was occasion-
ally observed in F0 transgenic embryos carrying different
deletion constructs of the dHAND promoter (Charite´ et al.,
2001). However, embryos generated with the 7.4-kb frag-
ment consistently showed the same abnormal limb bud
pattern as we have observed in our dHAND-Cre embryos
(J.C. and E.N.O. unpublished data). It is possible that the
limb bud represents a permissive environment for ectopic
transgene expression, or that an enhancer within the
7.4-kb upstream region acts in a promiscuous manner in
the absence of the full dHAND upstream region.
Potential roles of dHAND during facial development
By comparing -gal staining in dHAND-Cre;R26R and
dHAND-lacZ embryos, we can begin to integrate the tem-
poral expression of endogenous dHAND expression with
overall dHAND progeny cell fate. In this study, we found
labeled cells throughout the first pharyngeal arch of E10.5
dHAND-Cre;R26R and dHAND-lacZ embryos, with stain-
ing in E18.5 dHAND-Cre;R26R and dHAND-lacZ embryos
observed in numerous neural crest-derived structures, in-
cluding the mandible and Meckel’s cartilage. It is slightly
surprising that -gal staining in E18.5 dHAND-lacZ trans-
genic mice, while weaker, is similar to that observed in
E18.5 dHAND-Cre;R26R embryos. This likely does not
reflect aberrant activity of the dHAND pharyngeal arch
enhancer, as dHAND-specific expression of the dHAND-
lacZ transgene along arch arteries three and four and their
derivatives is correctly downregulated by E13.5 (unpub-
lished observations). Rather, these current findings suggest
that dHAND likely has multiple roles in facial development.
The first probably occurs during patterning of neural crest
cells and their derivatives that will eventually form the
facial skeleton. It is at this time (E9.5–E10.5) that -gal
staining was first observed in the arches of both dHAND-
Cre;R26R and dHAND-lacZ embryos, coinciding with the
endogenous expression pattern of dHAND. Further, while
dHAND/ embryos die by E10.5, disruption of mandibular
development is already apparent (Thomas et al., 1998).
Thus, it appears that dHAND function is crucial for the
early development of postmigratory neural crest cells.
The second role appears to be later in jaw development,
during which the dHAND-lacZ transgene is expressed in
structures undergoing osteogenesis and chondrogenesis. In
chondrogenic structures, labeled cells in E18.5 dHAND-
Cre;R26R embryos are observed throughout the cartilage,
whereas labeled cells in E18.5 dHAND-lacZ embryos are
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Fig. 5. Contribution of dHAND progeny cells during odontogenesis in dHAND-Cre;R26R embryos. Transverse (A–L) and frontal (M–R) sections through
the heads of dHAND-Cre;R26R (A, D, G, J, M, P), dHAND-lacZ (B, E, H, K, N, Q), and wild type (C, F, I, L, O, R) embryos. Treatment of sections was
performed as described in Fig. 3. (A–C) Transverse sections through the incisors of E13.5 embryos. (A, B) Labeled cells in dHAND-Cre;R26R and
dHAND-lacZ embryos are apparent throughout the developing lower jaw, including in Meckel’s cartilage (mc) and mesenchyme destined to become dentin
and pulp of the lower incisors. Labeled cells are not observed in the oral epithelium (oep) or developing enamel organ (eo). (C) dHAND expression in wild
type embryos is observed in the tongue (t) and mesenchyme surrounding the incisor enamel organs. Less expression is observed in Meckel’s cartilage. (D–F)
Transverse sections through the molar of E13.5 embryos, showing developing dentition of the molar at the late bud stage. (D) Labeled cells in
dHAND-Cre;R26R embryos are observed in the mesenchyme surrounding the bud of the developing mandibular molar (mdm; arrows) and mandibular bone
(md). Oral epithelium and developing enamel organs (*) of both maxillary (mxm) and mandibular molars are unlabeled. (E) Labeled cells in dHAND-lacZ
embryos are not observed surrounding the mandibular molar buds (arrow). (F) Endogenous dHAND expression is also not observed surrounding the
mandibular molar buds (arrow). (G–I) Transverse sections through the incisors of E15.5 embryos. The incisors have progressed to a cap stage, approaching
the “bell” configuration. (G) The nonlabeled enamel organ in dHAND-Cre;R26R embryos partially encases the labeled dental papilla (dp) and appears
irregular in shape due to the transverse angle of the section. The symphysis of Meckel’s cartilage is almost completely composed of labeled cells. (H) Labeled
cells in
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mainly confined to the perichondrium surrounding the car-
tilages. This suggests a limited role for dHAND in late
chondrogenesis, such as possibly maintaining the prolifer-
ative environment surrounding developing cartilages in the
jaw and throat. Past and active expression of the dHAND
transgenes appears more equal in osteogenic structures in
E18.5 embryos. Numerous genes and signaling pathways
are involved in osteogenesis (Karsenty and Wagner, 2002);
based on our current findings, it will be interesting to ex-
amine dHAND expression in mice lacking these genes to
determine potential roles for dHAND in signaling pathways
crucial for osteogenesis.
Positively defining the roles of dHAND, particularly in
E18.5 embryos, is difficult due to the lack of correlation
between endogenous dHAND expression and expression of
a dHAND-lacZ transgene. Promoter–lacZ transgenic con-
structs or lacZ gene cassettes used to inactivate genes are
routinely used to define gene expression patterns. However,
we have shown here that -gal staining is present even
when endogenous gene expression is below the level of
detection. This could reflect the relative stability of the lacZ
message compared with that of the dHAND message. Fur-
ther, while the half-life of dHAND protein is not known, in
vitro experiments have shown that nuclear-localized -ga-
lactosidase enzyme maintains 100% activity for at least 10 h
(Tsuneoka and Mekada, 1992) and has a half-life of at least
20–30 h in cultured cells (Bachmair et al., 1986; Gonda et
al., 1989). Because of this stability, it is quite likely that a
low level of gene expression would result in a much larger
pool of -gal enzyme, thus making detection much easier
compared with detection of mRNAs by in situ hybridization
analysis. More study of this point needs to be conducted to
fully understand the basis of these observations, and sug-
gests that some caution should be taken when using -gal
staining to define temporal patterns of gene expression.
dHAND expression within subsets of cephalic neural crest
cells
We have shown in this study that dHAND progeny cells
compose most of the bone, cartilage, and connective tissue
of the lower jaw, suggesting a significant role for dHAND
in cephalic neural crest cell development. However, while
neural crest cells contribute to the cartilaginous precursors
of malleus, incus, and stapes of the middle ear (Le Douarin,
1982; Noden, 1983, 1988), labeled cells in dHAND-Cre;
R26R embryos are only observed in the manubrium of the
malleus. This could indicate that one or more additional
enhancers are required in addition to the arch enhancer in
our construct to fully recapitulate the full dHAND expres-
sion domain within the arches. It is also possible that, while
early dHAND expression appears quite broad, dHAND ac-
tion within the neural crest derived ectomesenchyme is
highly compartmentalized. Fate map analysis of chick neu-
ral crest cells illustrates that the malleus is derived from
crest cells of different midbrain/hindbrain origins (Kontges
and Lumsden, 1996). This presumably reflects both the
origin and final spatial distribution of these cells within the
arches, as recent studies suggest that neural crest cells are
patterned by both signals in the neural tube and environ-
mental signals encountered during migration into the arches
(Trainor and Krumlauf, 2000; Trainor et al., 2002). It is
possible that our results reflect a similar mixed contribution
in mouse embryos, with dHAND (or at least individual
dHAND enhancers) participating in the development of
neural crest cells from specific midbrain/hindbrain origins
or those residing in specific arch subregions.
dHAND expression during odontogenesis
Another aspect of facial development that was uncovered
in our fate analysis was the difference in dHAND expression
between incisors and molars. During early development,
dHAND-progeny cells in dHAND-Cre;R26R embryos are
observed in both mandibular incisor and molar mesenchyme
and later, dental papilla, though actual gene expression is
only observed in cells in the incisor region. As mentioned
above, evidence of past expression (such as -gal staining in
dHAND-Cre;R26R embryos in the absence of current gene
expression) in developing structures does not necessarily
imply a direct function in structure formation. Further, nei-
ther incisor nor molar defects are observed in ETA/ em-
dHAND-lacZ embryos also compose most of the dental pulp of the incisor, in contrast to the mixing of labeled and unlabeled cells in the symphysis of
Meckel’s cartilage. (I) dHAND expression is observed in the dental pulp and surrounding mesenchyme. Expression is much weaker in Meckel’s cartilage
symphysis. (J–L) Transverse sections through the molar of E15.5 embryos. (J) In the mandibular molar, also in the cap stage, labeled cells in dHAND-Cre;
R26R embryos contribute to the dental papilla (arrow), though this area also contains unlabeled cells. (K) The dental papilla of mandibular molars from
dHAND-lacZ embryos is composed solely of unlabeled cells (arrow). (L) dHAND expression is not observed in the papilla of the mandibular molars (white
arrow), in contrast to the strong expression in the lamina propria of the tongue. (M–O) Frontal sections through the incisors of E18.5 embryos. (M) Labeled
cells in dHAND-Cre;R26R embryos appear in the dental papilla of the mandibular incisors, mandibular bone (md), Meckel’s cartilage, and surrounding
mesenchyme. Oral epithelium remains unlabeled, as does the developed enamel matrix (em). (N) A similar pattern of staining is observed in the incisors of
dHAND-lacZ embryos, though few labeled cells are observed in Meckel’s cartilage. (O) dHAND expression is observed in the incisor dental pulp, surrounding
bone, and mesenchyme. Very little expression is observed in Meckel’s cartilage. (P–R) Frontal sections through the molars of E18.5 embryos. (P) Labeled
cells in dHAND-Cre;R26R embryos appear in the dental papilla, although extensive mixing with unlabeled cells has occurred. Labeled cells are also observed
in the mandibular bone, Meckel’s cartilage, and surrounding connective tissue. The residual dental lamina (dl) can be seen connecting the unlabeled oral
epithelium and enamel organ. Labeled cells are not observed in mandibular nerves (arrow). (Q) Labeled cells in dHAND-lacZ embryos are confined to the
mandibular bone and Meckel’s cartilage. Labeled cells are not observed in the dental papilla of the molar. (R) A low level of dHAND expression is observed
in the mandibular bone surrounding the molar of wild type embryos, but expression is not observed in the molar dental pulp.
275L.-B. Ruest et al. / Developmental Biology 257 (2003) 263–277
bryos, in which expression of both dHAND and eHAND is
disrupted (Clouthier et al., 2000), suggesting that loss of
these two transcription factors alone does not disrupt odon-
togenesis. However, as dHAND progeny cells are observed
in both neural crest-derived incisor and molar dental papilla,
it is tempting to speculate that dHAND provides early
patterning information to crest cells that later populate the
dental papilla of the mandible and that it has redundant
functions with other mandibular arch genes. Studies of
multigene knockout embryos will be required to better ad-
dress this question.
In later development, dHAND expression remains in the
mesenchyme and dental papilla of the incisors, but not in the
molars. We cannot exclude the possibility that lack of molar
expression is due to absence of one or more as yet uniden-
tified arch enhancers required to fully recapitulate the en-
dogenous dHAND expression pattern. However, distinct
signaling pathways within the mandible are known to pat-
tern the dentition within the maxilla and mandible (Fergu-
son et al., 2000; Thomas et al., 2000). It is possible that
dHAND represents an “incisor-specific” gene, possibly
playing roles in both late tooth development and positioning
of the incisors within the mandible. Analysis of dHAND
expression in mouse mutants with defects in incisor and/or
molar development should help clarify dHAND’s role in
odontogenesis.
dHAND-Cre mice as a tool to investigate developmental
processes
Our present results demonstrate the power and utility of
using Cre-based fate mapping studies to understand possible
developmental functions of specific genes. More specifi-
cally, dHAND-Cre transgenic mice provide the opportunity
to follow the fate of dHAND lineage neural crest and
nonneural crest cells in different mouse mutant lines. Fur-
ther, these mice should be useful in concert with conditional
knockout mouse lines in dissecting the basis of multiple
developmental and disease processes.
Acknowledgments
We thank Bo Mason, Jennifer Beavin, Tim Morgan,
Shelly Dixon, Jian Xie, and Cassandra Evans for technical
assistance, and James E.T. Richardson for helpful discus-
sions. M.Y. is an investigator of the Howard Hughes Med-
ical Institute. D.E.C. is a recipient of a Career Development
Award from the NIDCR/NIH. This work was supported in
part by grants from the National Institutes of Health (to
D.E.C. and E.N.O.), the Kentucky Excellence in Education
Research Trust Fund (to D.E.C.), and the Donald W. Reyn-
olds Clinical Cardiovascular Research Center, Dallas, TX
(to E.N.O.).
References
Bachmair, A., Finley, D., Varshavsky, A., 1986. In vivo half-life of a
protein is a function of its amino-terminal residue. Science 234, 179–
186.
Bronner-Fraser, M., 1995. Origins and developmental potential of the
neural crest. Exp. Cell Res. 218, 405–417.
Carvajal, J.J., Cox, D., Summerbell, D., Rigby, P.W.J., 2001. A BAC
transgenic analysis of the Mrf4/Myf5 locus reveals interdigitated ele-
ments that control activation and maintenance of gene expression
during muscle development. Development 128, 1857–1868.
Chai, Y., Jiang, X., Ito, Y., Bringas, P., Han, J., Rositch, D.H., Soriano, P.,
McMahon, A.P., Sucov, H.M., 2000. Fate of the mammalian cranial
neural crest during tooth and mandibular morphogenesis. Development
127, 1671–1679.
Charite´, J., McFadden, D.G., Merlo, G.R., Levi, G., Clouthier, D.E.,
Yanagisawa, M., Richardson, J.A., Olson, E.N., 2001. Role of Dlx6 in
regulation of an endothelin-1-dependent, dHAND branchial arch en-
hancer. Genes Dev. 15, 3039–3049.
Charite´, J., McFadden, D.G., Olson, E.N., 2000. The bHLH transcription
factor dHAND controls Sonic hedgehog expression and establishment
of the zone of polarizing activity during limb development. Develop-
ment 127, 2461–2470.
Clouthier, D.E., Comerford, S.A., Hammer, R.E., 1997. Hepatic fibrosis,
glomerulosclerosis, and a lipodystrophy-like syndrome in PEPCK-
TGF-1 transgenic mice. J. Clin. Invest. 100, 2697–2713.
Clouthier, D.E., Hosoda, K., Richardson, J.A., Williams, S.C., Yanagi-
sawa, H., Kuwaki, T., Kumada, M., Hammer, R.E., Yanagisawa, M.,
1998. Cranial and cardiac neural crest defects in endothelin-A receptor-
deficient mice. Development 125, 813–824.
Clouthier, D.E., Williams, S.C., Yanagisawa, H., Wieduwilt, M., Richard-
son, J.A., Yanagisawa, M., 2000. Signaling pathways crucial for
craniofacial development revealed by endothelin-A receptor-deficient
mice. Dev. Biol. 217, 10–24.
Comerford, S.A., Maika, S.D., Laimins, L.A., Messing, A., Elsasser, H.P.,
Hammer, R.E., 1995. E6 and E7 expression from the HPV 18 LCR:
development of genital hyperplasia and neoplasia in transgenic mice.
Oncogene 10, 587–597.
Cserjesi, P., Brown, D., Lyons, G.E., Olson, E.N., 1995. Expression of the
novel basic helix–loop–helix gene eHAND in neural crest derivatives
and extraembryonic membranes during mouse development. Dev. Biol.
170, 664–678.
Dorsky, R.I., Moon, R.T., Raible, D.W., 1998. Control of neural crest cell
fate by the Wnt signalling pathway. Nature 396, 370–373.
Fekete, D.M., 1999. Development of the vertebrate ear: insights from
knockouts and mutants. Trends Neurosci. 22, 263–269.
Ferguson, C.A., Tucker, A.S., Sharpe, P.T., 2000. Temporospatial cell
interactions regulating mandibular and maxillary arch patterning. De-
velopment 127, 403–412.
Fernandez-Teran, M., Piedra, M.E., Kathiriya, I.S., Srivastava, D., Rodri-
guez-Rey, J.C., MA, R., 2000. Role of dHAND in the anterior–poste-
rior polarization of the limb bud: implications for the Sonic hedgehog
pathway. Development 127, 2133–2142.
Firulli, A.B., McFadden, D.G., Lin, Q., Srivastava, D., Olson, E.N., 1998.
Heart and extra-embryonic mesodermal defects in mouse embryos
lacking the bHLH transcription factor Hand1. Nat. Genet. 18, 266–270.
Francis-West, P., Ladher, R., Barlow, A., Graveson, A., 1998. Signalling
interactions during facial development. Mech. Dev. 75, 3–28.
Gonda, D.K., Bachmair, A., Wu¨nning, I., Tobias, J.W., Lane, W.S., Var-
shavsky, A., 1989. Universality and structure of the N-end rule. J. Biol.
Chem. 264, 16700–16712.
Hollenberg, S.M., Sternglanz, R., Cheng, P.F., Weintraub, H., 1995. Iden-
tification of a new family of tissue-specific basic helix-loop-helix
proteins with a two-hybrid screen. Mol. Cell. Biol. 15, 3813–3822.
276 L.-B. Ruest et al. / Developmental Biology 257 (2003) 263–277
Howard, M.J., Stanke, M., Schneider, C., Wu, X., Rohrer, H., 2000. The
transcription factor dHAND is a downstream effector of BMPs in
sympathetic neuron specification. Development 127, 4073–4081.
Ikeya, M., Lee, S.M.K., Johnson, J.E., McMahon, A.P., Takada, S., 1997.
Wnt signalling required for expansion of neural crest and CNS pro-
genitors. Nature 389, 966–970.
Jaskoll, T., Zhou, Y.M., Chai, Y., Makarenkova, H.P., Collinson, J.M.,
West, J.D., Hajihosseini, M.K., Lee, J., Melnick, M., 2002. Embryonic
submandibular gland morphogenesis: stage-specific protein localiza-
tion of FGFs, BMPs, Pax6 and Pax9 in normal mice and abnormal
SMG phenotypes in FgfR2-IIIc(/Delta), BMP7(/) and
Pax6(/) mice. Cells Tissues Organs 170, 83–98.
Jiang, X., Iseki, S., Maxson, R.E., Sucov, H.M., Morriss-Kay, G.M., 2002.
Tissue origins and interactions in the mammalian skull vault. Dev. Biol.
241, 106–116.
Karsenty, G., Wagner, E.F., 2002. Reaching a genetic and molecular
understanding of skeletal development. Dev. Cell 2, 389–406.
Kisanuki, Y.Y., Hammer, R.E., Miyazaki, J., Williams, S.C., Richardson,
J.A., Yanagisawa, M., 2001. Tie-2Cre transgenic mice: a new model
for endothelial cell- lineage analysis in vivo. Dev. Biol. 230, 230–242.
Kontges, G., Lumsden, A., 1996. Rhombencephalic neural crest segmen-
tation is preserved throughout craniofacial ontogeny. Development
122, 3229–3242.
Kraus,P.,Lufkin,T.(1999). Mammalian Dlx homeobox gene control of
craniofacial and inner ear morphogenesis J. Cell Biochem. Suppl.
32–33, 133–140.
Le Douarin, N.M., 1982. The Neural Crest. Cambridge Univ. Press, Cam-
bridge.
Le Douarin, N.M., Ziller, C., Couly, G.F., 1993. Patterning of neural crest
derivatives in the avian embryo: in vivo and in vitro studies. Dev. Biol.
159, 24–49.
Mallo, M., 2001. Formation of the middle ear: recent progress on the
developmental and molecular mechanisms. Dev. Biol. 231, 410–419.
McFadden, D.G., Charite´, J., Richardson, J.A., Srivastava, D., Firulli, A.B.,
Olson, E.N., 2000. A GATA-dependent right ventricular enhancer
controls dHAND transcription in the developing heart. Development
127, 5331–5341.
Merlo, G.R., Zerega, B., Paleari, L., Trombino, S., Mantero, S., Levi, G.,
2000. Multiple functions of Dlx genes. Int. J. Dev. Biol. 44, 619–626.
Mina, M., 2001. Regulation of mandibular growth and morphogenesis.
Crit. Rev. Oral Biol. Med. 12, 276–300.
Noden, D.M., 1983. The role of the neural crest in patterning of avian
cranial skeletal, connective, and muscle tissues. Dev. Biol. 96, 144–
165.
Noden, D.M., 1988. Interactions and fates of avian craniofacial mesen-
chyme. Development 103, 121–140.
O’Gorman, S., Dagenais, N.A., Qian, M., Marchuk, Y., 1997. Protamine-
Cre recombinase transgenes efficiently recombine target sequences in
the male germ line of mice, but not in embryonic stem cells. Proc. Natl.
Acad. Sci. USA 94, 14602–14607.
Riley, P., Anson-Cartwright, L., Cross, J.C., 1998. The Hand1 bHLH
transcription factor is essential for placentation and cardiac morpho-
genesis. Nat. Genet. 18, 271–275.
Schorle, H., Meier, P., Buchert, M., Jaenisch, R., Mitchell, P.J., 1996.
Transcription factor AP-2 essential for cranial closure and craniofacial
development. Nature 381, 235–238.
Serbedzija, G.N., Bronner-Fraser, M., Fraser, S.E., 1992. Vital dye analysis
of cranial neural crest cell migration in the mouse embryo. Develop-
ment 116, 297–307.
Shelton, J.M., Lee, M.-H.,Richardson, J.A., S., P. (2000). Microsomal
triglyceride transfer protein expression during mouse development. J.
Lipid Res. 41, 532–537.
Soriano, P., 1997. The PDGF receptor is required for neural crest cell
development and for normal patterning of the somites. Development
124, 2691–2700.
Soriano, P., 1999. Generalized lacZ expression with the ROSA26 Cre
reporter strain. Nat. Genet. 21, 70–71.
Srivastava, D., Cserjesi, P., Olson, E.N., 1995. A subclass of bHLH
proteins required for cardiac morphogenesis. Science 270, 1995–1999.
Srivastava, D., Thomas, T., Lin, Q., Kirby, M.L., Brown, D., Olson, E.N.,
1997. Regulation of cardiac mesodermal and neural crest development
by the bHLH transcription factor, dHAND. Nat. Genet. 16, 154–160.
Thomas, B.L., Liu, J.K., Rubenstein, J.L.R., Sharpe, P.T., 2000. Indepen-
dent regulation of Dlx2 expression in the epithelium and mesenchyme
of the first branchial arch. Development 127, 217–224.
Thomas, B.L., Sharpe, P.T., 1998. Patterning of the murine dentition by
homeobox genes. Eur. J. Oral Sci. 106 (Suppl. 1), 48–54.
Thomas, T., Kurihara, H., Yamagishi, H., Kurihara, Y., Yazaki, Y., Olson,
E.N., Srivastava, D., 1998. A signaling cascade involving endothelin-1,
dHAND and Msx1 regulates development of neural-crest-derived
branchial arch mesenchyme. Development 125, 3005–3014.
Trainor, P., Krumlauf, R., 2000. Plasticity in mouse neural crest cells
reveals a new patterning role for cranial mesoderm. Nat. Cell Biol. 2,
96–102.
Trainor, P.A., Ariza-McNaughton, L., Krumlauf, R., 2002. Role of the
isthmus and FGFs in resolving the paradox of neural Crest plasticity
and prepatterning. Science 295, 1288–1291.
Tsuneoka, M., Mekada, E., 1992. Degradation of a nuclear-localized pro-
tein in mammalian COS cells, using Escherichia coli -galactosidase
as a model protein. J. Biol. Chem. 267, 9107–9111.
Tucker, S.A., Yamada, G., Grigoriou, M., Pachnis, V., Sharpe, P.T., 1999.
Fgf-8 determines rostral-caudal polarity in the first branchial arch.
Development 126, 51–61.
Wilkie, A.O., Morriss-Kay, G.M., 2001. Genetics of craniofacial develop-
ment and malformation. Nat. Rev. Genet. 2, 458–468.
Zhang, J., Hagopian-Donaldson, S., Serbedzija, G., Elsemore, J., Plehn-
Dujowich, D., McMahon, A.P., Flavell, R.A., Williams, T., 1996.
Neural tube, skeletal and body wall defects in mice lacking transcrip-
tion factor AP-2. Nature 381, 238–241.
277L.-B. Ruest et al. / Developmental Biology 257 (2003) 263–277
